Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5936)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 15, 2022 (publication date) through May 20, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Florentin M, Kostapanos MS, Papazafiropoulou AK. Role of dipeptidyl peptidase 4 inhibitors in the new era of antidiabetic treatment. World J Diabetes 2022; 13(2): 85-96 [PMID: 35211246 DOI: 10.4239/wjd.v13.i2.85] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v13/i2/85.htm |
| Number | Citing Articles |
| 1 |
Shinichiro Shirabe, Katsuya Yamazaki, Mariko Oishi, Keiko Arai, Noriharu Yagi, Manaka Sato, Masakazu Takeuchi, Takahito Kai, Hiroshi Maegawa. Changes in prescription patterns and doses of oral antidiabetic drugs in Japanese patients with type 2 diabetes (JDDM70). Journal of Diabetes Investigation 2023; 14(1): 75 doi: 10.1111/jdi.13922
|
| 2 |
Eiji Kobayashi, Yusuke Kamihara, Miho Arai, Akinori Wada, Shohei Kikuchi, Ryo Hatano, Noriaki Iwao, Takeshi Susukida, Tatsuhiko Ozawa, Yuichi Adachi, Hiroyuki Kishi, Nam H. Dang, Taketo Yamada, Yoshihiro Hayakawa, Chikao Morimoto, Tsutomu Sato. Development of a Novel CD26-Targeted Chimeric Antigen Receptor T-Cell Therapy for CD26-Expressing T-Cell Malignancies. Cells 2023; 12(16): 2059 doi: 10.3390/cells12162059
|
| 3 |
Peng Ning, Xiaobo Jiang, Jing Yang, Jiaxing Zhang, Fan Yang, Hongyi Cao. Mitophagy: A potential therapeutic target for insulin resistance. Frontiers in Physiology 2022; 13 doi: 10.3389/fphys.2022.957968
|
| 4 |
Masaaki Yoshida, Taiki Kokubun, Kota Sato, Satoru Tsuda, Yu Yokoyama, Noriko Himori, Toru Nakazawa. DPP-4 Inhibitors Attenuate Fibrosis After Glaucoma Filtering Surgery by Suppressing the TGF-β/Smad Signaling Pathway. Investigative Opthalmology & Visual Science 2023; 64(10): 2 doi: 10.1167/iovs.64.10.2
|
| 5 |
Yarini Arrebola Sánchez, Fabiola Almeida García, Daniel Ojeda del Sol, Mario E. Valdés-Tresanco, Carlos David Ortiz, Belinda Sánchez Ramírez, Isel Pascual Alonso. Dipeptidyl peptidase IV: a multifunctional enzyme with implications in several pathologies including cancer. Physical Sciences Reviews 2023; 0(0) doi: 10.1515/psr-2022-0288
|
| 6 |
Kyoko Oura, Asahiro Morishita, Joji Tani, Tsutomu Masaki. Antitumor Effects and Mechanisms of Metabolic Syndrome Medications on Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2022; : 1279 doi: 10.2147/JHC.S392051
|
| 7 |
Jennifer Okemah, Sola Neunie, Alexander Noble, Carol Wysham. Impact on Knowledge, Competence, and Performance of a Faculty-Led Web-Based Educational Activity for Type 2 Diabetes and Obesity: Questionnaire Study Among Health Care Professionals and Analysis of Anonymized Patient Records. JMIR Formative Research 2023; 7: e49115 doi: 10.2196/49115
|
| 8 |
Fen Zhuge, Liujie Zheng, Yuxiang Pan, Liyang Ni, Zhengwei Fu, Junping Shi, Yinhua Ni. DPP-4 inhibition by linagliptin ameliorates age-related mild cognitive impairment by regulating microglia polarization in mice. Experimental Neurology 2024; 373: 114689 doi: 10.1016/j.expneurol.2024.114689
|
| 9 |
A.B.M. Kamrul-Hasan, Muhammad Shah Alam, Samir Kumar Talukder, Deep Dutta, Shahjada Selim. Efficacy and Safety of Omarigliptin, a Novel Once-Weekly Dipeptidyl Peptidase-4 Inhibitor, in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Endocrinology and Metabolism 2024; 39(1): 109 doi: 10.3803/EnM.2023.1839
|
| 10 |
Awadhesh Kumar Singh, Ritu Singh. Relook at DPP-4 inhibitors in the era of SGLT-2 inhibitors. World Journal of Diabetes 2022; 13(6): 466-470 doi: 10.4239/wjd.v13.i6.466
Abstract(424) |
Core Tip(461) |
Full Article(HTML)(2079)
|
Full Article (PDF)-641K(303)
|
Full Article (Word)-43K(72)
|
Audio-743K(0)
|
Peer-Review Report-179K(71)
|
Answering Reviewers-121K(55)
|
Times Cited (0)
|
Total Visits (5453)
|
Open
|
| 11 |
György Jermendy, Zoltán Kiss, György Rokszin, Zsolt Abonyi-Tóth, Csaba Lengyel, Péter Kempler, István Wittmann. Changing Patterns of Antihyperglycaemic Treatment among Patients with Type 2 Diabetes in Hungary between 2015 and 2020—Nationwide Data from a Register-Based Analysis. Medicina 2022; 58(10): 1382 doi: 10.3390/medicina58101382
|
| 12 |
A.B.M. Kamrul-Hasan, Muhammad Shah Alam, Samir Kumar Talukder, Deep Dutta, Shahjada Selim. Efficacy and Safety of Omarigliptin, a Novel Once-Weekly Dipeptidyl Peptidase-4 Inhibitor, in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Endocrinology and Metabolism 2024; 39(1): 109 doi: 10.3803/EnM.2024.1839
|
| 13 |
Aleksandra Pilszyk, Magdalena Niebrzydowska, Zuzanna Pilszyk, Magdalena Wierzchowska-Opoka, Żaneta Kimber-Trojnar. Incretins as a Potential Treatment Option for Gestational Diabetes Mellitus. International Journal of Molecular Sciences 2022; 23(17): 10101 doi: 10.3390/ijms231710101
|